Enveric Biosciences, Inc. 8-K

What Happened
Enveric Biosciences, Inc. (ENVB) filed a Current Report on Form 8-K (Item 7.01) to disclose that management prepared an "Investor Presentation" it intends to release on the company's website on or about January 9, 2026. The presentation is furnished as Exhibit 99.1 to the 8-K and may be used, possibly with modifications, in future presentations to investors, analysts, lenders, partners, acquisition candidates, customers and employees. The company notes the materials on its website are not incorporated by reference into the 8-K and, consistent with General Instruction B.2 of Form 8-K, the furnished presentation is not "filed" for purposes of Section 18 of the Exchange Act.

Key Details

• Filed on Form 8-K under Item 7.01 (Regulation FD disclosure); Exhibit 99.1 contains the Investor Presentation.
• Management intends to post the presentation on or about January 9, 2026.
• Presentation will be available at: https://www.enveric.com/investors/events/.
• Company states web materials and Exhibit 99.1 are furnished (not filed) and not subject to Section 18 liability or automatic incorporation by reference.

Why It Matters
For investors, this 8-K signals Enveric is providing an updated investor presentation that management plans to use when communicating with stakeholders. The posted presentation is an accessible source of the company's latest messaging, strategy and program highlights; however, because it was furnished (not filed), it is not subject to the same legal incorporation or liability protections as filed disclosures. Investors who want the latest company details should review Exhibit 99.1 and the presentation on Enveric’s investor site.